Announcements

HyperSpectral Named a 2025 R&D 100 Finalist for SpecAI™ Platform

Modern building with large glass windows supported by angled concrete beams and a lone tree outside.

author

Lauren Stack

date

August 18, 2025

read time

2 min

Share Article

Heading 1

Heading 2

Heading 3

Heading 4

Heading 5
Heading 6

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.

Block quote

Ordered list

  1. Item 1
  2. Item 2
  3. Item 3

Unordered list

  • Item A
  • Item B
  • Item C

Text link

Bold text

Emphasis

Superscript

Subscript

SpecAI™ recognized as a top innovation in spectral AI for accessible diagnostics in the Software/Services category ALEXANDRIA, VA (August 15, 2025) – HyperSpectral, the world’s...

SpecAI™ recognized as a top innovation in spectral AI for accessible diagnostics in the Software/Services category

ALEXANDRIA, VA (August 15, 2025) – HyperSpectral, the world’s first AI-powered spectral intelligence company with hardware-agnostic solutions for particle detection, has been named a Finalist in the Software/Services category of the 2025 R&D 100 Awards for its SpecAI™ platform. The prestigious R&D 100 competition, now in its 63rd year, celebrates groundbreaking technologies and products that combine scientific breakthroughs with real-world applicability. 

In announcing the finalists, R&D World highlighted the importance of digital innovation across sectors—from health care to environmental sciences—and recognized SpecAI™ for pushing the boundaries of conventional image-based diagnostics by extracting deep insights from spectral data. The SpecAI™ platform leverages advanced deep learning to rapidly identify pathogens in a low-cost, portable, and culture-free format. 

“It’s an honor to be recognized among the 2025 R&D 100 Finalists,” said Matt Theurer, co-founder and CEO of HyperSpectral. “SpecAI™ was designed to transcend traditional imaging barriers by harnessing spectral AI, and this acknowledgment underscores our mission to revolutionize diagnostics in health care, food safety, and other sectors through innovative technology.” 

The R&D 100 Awards, often described as the “Oscars of Innovation,” is the only global competition that annually honors the top 100 commercially available or licensable technologies with significant scientific and engineering impact. Selected by an international panel of 54 expert judges, this year’s finalists were officially announced on August 13, 2025, with winners to be revealed in the weeks that follow. 

About HyperSpectral 

Based in Alexandria, VA, HyperSpectral seeks to combine spectroscopy, AI, and machine learning to illuminate invisible threats. HyperSpectral is actively working to provide the medical technology, defense industry, and agricultural sectors with real-time intelligence on product safety and protect people from invisible threats. For more information, visit https://www.hyperspectral.ai/

Keep Reading

Related Insights

Announcements

HyperSpectral & DARPA Extend Collaboration to Enhance Integrity of Domestic Supply Chain

December 2, 2024

Announcements

HyperSpectral Appoints Dr. Rob Donofrio as Chief Life Science Officer to Accelerate Adoption of Spectral Intelligence Platform Across Life Sciences, MedTech & Public Health

December 10, 2025

Announcements

HyperSpectral Secures Spot on 2024 FoodTech 500, Showcasing AI-Powered Food Safety Innovation

March 18, 2025